RefleXion

Manufacturing · California, United States · 201-500 Employees

View Company Info for Free

Overview

Headquarters

25841 Industrial Blvd Ste 275, Hayward, ...

Phone Number

(650) 239-9070

Revenue

$114.1 Million

Industry

Manufacturing Business Services Research & Development Medical Devices & Equipment Test & Measurement Equipment
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
5
4
1
1
1
1

About RefleXion

RefleXion is a biotargeting oncology company. it offers cancer care, radiation therapy, and life sciences. The company was founded in 2009 and is based in Hayward, California.Explore more
RefleXion's Social MediaPopular SearchesRefleXionReflexion MedicalRefleXion Medical IncReflexion IncUSRefleXion Medical IncSIC Code 38,384NAICS Code 33,334Show more

RefleXion Org Chart

GC
United States flag for contact location.

Chief Executive Officer

PhoneEmail
Samuel Mazin, Founder & Chief Technology Officer at RefleXion
United States flag for contact location.

Founder & Chief Technology Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
DL
United States flag for contact location.

Senior VP, Research & Development

PhoneEmail
JJ
United States flag for contact location.

Vice President, Software Engineering

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is RefleXion your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to RefleXion

Compare insights from companies similar to RefleXion, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

RefleXion

$114.1M
201-500
Private
$587.6M
2009
$151.6M
501-1,000
Public
$90M
2003
DR
Daniel ReuversPresident & CEO
$70M
201-500
Private
<$5M
1987
DD
David DeignanCEO & President & Member Board of Directors
$47.4M
51-200
Private
$11.3M
1997
TE
Thomas EisimingerPresident & CEO
$32.5M
51-200
Public
-
2000
$29.8M
51-200
Private
<$5M
1997
<$5M
201-500
Public
$100M
2018
Lynn Seely, President & Chief Executive Officer at Lyell Immunopharma
Lynn SeelyPresident & CEO
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

RefleXion is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

RefleXion is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about RefleXion.

RefleXion financials insights

Gather financial insights about RefleXion, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2014

Series A

$11.6M

2016

Series B

$6M

2018

Series C

$100M

2019

Unspecified

$60M

2020

Private Equity

$100M

2022

Private Equity

$80M

Debt

$125M

2023

Other Financing Round

$105M

See All RefleXion's Financials Insights

RefleXion Tech Stack

A closer look at the technologies used by RefleXion

Most Recent Scoops

Person-Based
Open Position
Event
Person-Based
Anthony Tran, Inventory Control Specialist, appeared on a podcast called "Founder's Story" on 09/30/2025. Topics discussed include Crypto, NFTs, Banksy, Xion, Web3.
Events, Podcast
Award
Award, Product Development, Healthcare Technology
Executive Move
Commentary
Person-Based
Executive Moves, Personnel Moves
See more scoops

RefleXion News & Media

  • RefleXion Announces Executive Appointments

    HAYWARD, Calif.--(BUSINESS WIRE)-- #RefleXion--RefleXion Medical, a theranostic oncology company, today announced the appointment of Steve Schoch as chief financial officer (CFO) and the promotion of Phil Aulson to chief operating officer (COO). Both report to Todd Powell, RefleXion’s president and chief executive officer. “Steve’s 30-year track record of excellence and diverse background will be a tremendous asset to the RefleXion team,” said Powell. “He brings extensive experience in fundraisi
  • RefleXion Expands Access to SCINTIX Therapy with First Freestanding Cancer Center

    HAYWARD, Calif.--(BUSINESS WIRE)-- #RefleXion--RefleXion Medical, a theranostic oncology company, today announced the scheduled installation of its RefleXion® X1 platform with SCINTIX® biology-guided radiotherapy at Beverly Hills Cancer Center (BHCC), the first freestanding cancer center (FSCC) that has installed the RefleXion X1. “At BHCC, we are committed to advancing cancer care by integrating the latest innovations, ensuring our patients receive the highest quality, cutting-edge treatments,”
  • RefleXion Launches Pivotal Study to Expand SCINTIX Therapy and Announces Broader Medicare Reimbursement

    HAYWARD, Calif.--(BUSINESS WIRE)-- #CancerTherapy--RefleXion® Medical, an external-beam theranostic oncology company, today announced initiation of the BIOGUIDE-X2 clinical study to expand indications for SCINTIX® biology-guided radiotherapy at Hackensack Meridian John Theurer Cancer Center, a research partner with Georgetown’s Lombardi Comprehensive Cancer Center, an NCI-designated comprehensive cancer center. The company also announced key updates from the Centers for Medicare and Medicaid (CM
  • RefleXion Showcases Pioneering Multi-Target Treatment (MTT) and Early Clinical Highlights at ASTRO

    HAYWARD, Calif.--(BUSINESS WIRE)-- #ASTRO2024--RefleXion® Medical, an external-beam theranostic oncology company, today announced it will showcase Multi-target Treatment (MTT), the groundbreaking upgrade for its RefleXion® X1 platform. This innovation allows physicians to combine SCINTIX® biology-guided radiotherapy with conventional stereotactic body radiotherapy (SBRT) in a single plan to treat patients with metastatic disease. The company will also highlight learnings from its early patient t
Read more news

Top Manufacturing Companies

Frequently Asked Questions Regarding RefleXion

What is RefleXion's official website?
RefleXion's official website is www.reflexion.com
What is RefleXion's Revenue?
RefleXion's revenue is $114.1 Million
What is RefleXion's SIC code?
RefleXion's SIC: 38,384
What is RefleXion's NAICS code?
RefleXion's NAICS: 33,334
How many employees does RefleXion have?
RefleXion has 201-500 employees
What industry does RefleXion belong to?
RefleXion is in the industry of: Manufacturing, Business Services, Research & Development
What is RefleXion competition?
RefleXion top competitors include: Neuronetics, Vasomedical, Lyell Immunopharma, Regenesis Biomedical
What technology does RefleXion use?
Some of the popular technologies that RefleXion uses are: goo.gl, Freshservice, Cloudflare Rocket Loader, Zingfit
Who is the CTO of RefleXion?
RefleXion's CTO is Samuel Mazin
How do I contact RefleXion?
RefleXion contact info: Phone number: (650) 239-9070 Website: www.reflexion.com
What does RefleXion do?

RefleXion is a biotargeting oncology company. it offers cancer care, radiation therapy, and life sciences. The company was founded in 2009 and is based in Hayward, California.... Read More

What are RefleXion social media links?
RefleXion Linkedin page RefleXion Twitter page RefleXion Facebook page
Who invested in RefleXion?
RefleXion has 27 investors including Venrock, KCK, Sofinnova Partners and Venrock.
Is RefleXion a public company?
RefleXion is private company therefore does not currently have an official ticker symbol
See more information about RefleXion

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.